On May 7, 2026, iBio, Inc. appointed Dr. Elizabeth Stoner as a Class II director and member of the Compensation Committee, while Evert Schimmelpennink resigned from the Board, effective immediately. This reorganization is significant for the company's governance, indicating a fresh strategic direction.